<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-10T14:20:01Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.j00217.04539" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.j00217.04539</identifier>
    <datestamp>2024-12-02T12:58:52Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2024-12-02</dc:date>
  <dc:title>Preparation of universal HER2-specific CAR-T cells expressed HLA-G and evaluation their resistance to NK cells killing effect</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.j00217.04539</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Objective This study aimed to prepare universal human growth factor receptor 2(HER2)-specific chimeric antigen receptor T cells expressing human leukocyte antigen G(HLA-G),named&amp;quot;GU HER2 CAR-T&amp;quot;,and to detect their ability to resist NK cells-induced killing effect and their ability to kill HER2-positive tumor cells.Methods Lentivirus was produced in 293-T cells by using a humanized single chain antibody P1h2 CAR lentivirus vector expressing HLA-G and targeting HER2.HER2-specific CAR-T cells expressing HLA-G(HLA-G HER2 CAR-T)were obtained by transduction of healthy human T cells with the lentivirus.The GU HER2 CAR-T cells were obtained by using clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated protein 9(Cas9)gene-editing technology to knockout the T cell receptor(TCR)and human leukocyte antigen Ⅰ(HLA-Ⅰ)in HLA-G HER2 CAR-T cells.The killing ability of GU HER2 CAR-T cells against tumor cells was evaluated by CCK-8 assay.Allogeneic peripheral blood mononuclear cells(PBMC)immune rejection response to GU HER2 CAR-T was detected by cells co-culture assay.Luciferase assay was used to evaluate the killing capacity of NK92 cells on GU HER2 CAR-T.Results The GU HER2 CAR-T cells were prepared and could kill HER2 positive tumor cells specifically.The GU HER2 CAR-T cells could also resist immune rejection by allogeneic PBMC and resist killing by NK92 cells.Conclusion The GU HER2 CAR-T cells can resist NK cells-induced cytotoxicity,laying a foundation for improving the sustained killing of HER2 positive tumor cells by universal allogeneic CAR-T.</dc:description>
  <dc:subject>Human leukocyte antigen G; Epidermal growth factor receptor 2; Chimeric antigen receptor T cells; Natural killer cells; Cell killing</dc:subject>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>